India Highlights "Public Interest" To Reign In Prices For Non-Scheduled Drugs

India's National Pharmaceutical Pricing Authority has imposed a 15-day deadline on 11 drug manufacturers to rein in costs of certain drugs, citing the "public interest" of lower prices for consumers